Analysis of prognosis in non-small cell lung cancer patients with platinum-based chemotherapy and bone marrow suppression

被引：0
作者：
Han, B. [1 ]
机构：
[1] Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e17532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17532
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Genome-Wide Association Study of Prognosis in Advanced Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
    Hu, Lingmin
    Wu, Chen
    Zhao, Xueying
    Heist, Rebecca
    Su, Li
    Zhao, Yang
    Han, Baohui
    Cao, Songyu
    Chu, Minjie
    Dai, Juncheng
    Dong, Jing
    Shu, Yongqian
    Xu, Lin
    Chen, Yijiang
    Wang, Yi
    Lu, Feng
    Jiang, Yue
    Yu, Dianke
    Chen, Hongyan
    Tan, Wen
    Ma, Hongxia
    Chen, Jiaping
    Jin, Guangfu
    Wu, Tangchun
    Lu, Daru
    Christiani, David C.
    Lin, Dongxin
    Hu, Zhibin
    Shen, Hongbing
    CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5507 - 5514
  • [12] Overexpression of MAC30 is Resistant to Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer
    Chen, Ruhua
    Fen, Yan
    Lin, Xubo
    Ma, Tieliang
    Cai, Hourong
    Ding, Hui
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (06) : 815 - 820
  • [13] TOLERABILITY OF STANDARD DOSE OF PLATINUM-BASED CHEMOTHERAPY IN FIT ELDERLY PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Zenke, Y.
    Umemura, S.
    Yoh, K.
    Matsumoto, S.
    Niho, S.
    Goto, K.
    Ohmatsu, H.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [14] Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World
    Giacomo Pelizzari
    Francesco Cortiula
    Marco Giavarra
    Michele Bartoletti
    Camilla Lisanti
    Vanessa Buoro
    Monica Cattaneo
    Ciro Rossetto
    Simona Rizzato
    Fabio Puglisi
    Marianna Macerelli
    Gianpiero Fasola
    Alessandro Follador
    Drugs & Aging, 2020, 37 : 677 - 689
  • [15] Comorbidity as a Prognostic Factor in Elderly Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Sazdanic-Velikic, Danica
    Tepavac, Aleksandar
    Lalic, Nensi
    Stojkovic, Ivana
    Secen, Nevena
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S914 - S914
  • [16] Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Mellema, Wouter W.
    van der Hoek, Dorien
    Postmus, Pieter E.
    Smit, Egbert F.
    LUNG CANCER, 2014, 86 (01) : 73 - 77
  • [17] Clinical study of platinum-based chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer
    Zhang, Xiaotong
    Li, Longyun
    Lu, Bo
    CHEST, 2007, 132 (04) : 590S - 591S
  • [18] PROGNOSTIC IMPORTANCE OF RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Radosavljevic, D.
    Kezic, I.
    Jelic, S.
    Golubicic, I.
    ANNALS OF ONCOLOGY, 2008, 19 : 111 - 111
  • [19] DECREASE OF CIRCULATING TUMOR CELLS ASSOCIATES WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER, BUT NOT WITH SMALL CELL LUNG CANCER
    Gauler, Thomas C.
    Theegarten, Dirk
    Parr, Annette
    Schuhr, Ivonne
    Schmid, Kurt W.
    Eberhardt, Wilfried
    Schuler, Martin
    Hoffmann, Andreas-Claudius
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1114 - S1114
  • [20] Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients
    Qian, Lei
    Ding, Xiao
    Li, Fang-Qi
    Tian, Hui-Min
    Chen, Xiao
    Han, Fu-Jun
    Wang, Hong-Yi
    Li, Wen-Qian
    Niu, Chao
    Xu, Jian-Ting
    Li, Zhao-Zhi
    He, Hua
    Cui, Jiu-Wei
    NEOPLASMA, 2023, 70 (02) : 251 - 259
12345